Premium
Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID‐19 without hydroxychloroquine use: Report of the first case
Author(s) -
Atak Mehmet Fatih,
Farabi Banu,
Akbayrak Atiye,
Kalelioğlu Mehmet Berati,
Rao Babar K.
Publication year - 2021
Publication title -
journal of cosmetic dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.626
H-Index - 44
eISSN - 1473-2165
pISSN - 1473-2130
DOI - 10.1111/jocd.14304
Subject(s) - acute generalized exanthematous pustulosis , hydroxychloroquine , covid-19 , favipiravir , dermatology , medicine , pharmacovigilance , virology , pharmacology , adverse effect , outbreak , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom